Telomir Pharmaceuticals, Inc. Shareholders' Equity
Telomir Pharmaceuticals, Inc. (TELO) had Shareholders' Equity of $5.03 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-13
- 2026-06-30: Stockholders' Equity Attributable to Parent $5.03M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $4.96M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $5.91M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $6.98M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-06-30 | $5.03M 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $4.96M 10-Q · filed 2026-08-13 | |
| 2025-12-31 | $5.91M 10-Q · filed 2026-08-13 | |
| 2025-09-30 | $6.98M 10-Q · filed 2025-11-10 | |
| 2025-06-30 | $481.22K 10-Q · filed 2026-08-13 | |
| 2025-03-31 | -$161.10K 10-Q · filed 2026-08-13 | -$161.11K 10-Q · filed 2025-05-14 |
| 2024-12-31 | $643.04K 10-Q · filed 2026-08-13 | |
| 2024-09-30 | $442.07K 10-Q · filed 2025-11-10 | |
| 2024-06-30 | $1.63M 10-Q · filed 2025-11-10 | $1.57M 10-Q · filed 2024-08-13 |
| 2024-03-31 | $3.02M 10-Q · filed 2025-11-10 | |
| 2023-12-31 | $3.44M 10-K · filed 2026-03-17 | |
| 2023-09-30 | $2.18M 10-Q · filed 2024-11-12 | $2.18M 10-Q · filed 2024-05-13 |
| 2023-06-30 | $3.89M 10-Q · filed 2024-11-12 | $3.89M 10-Q · filed 2024-05-13 |
| 2023-03-31 | -$510.21K 10-Q · filed 2024-08-13 | -$510.22K 10-Q · filed 2024-05-13 |
| 2022-12-31 | -$937.28K 10-K · filed 2025-02-04 | |
| 2021-12-31 | -$138.13K 10-K · filed 2024-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lexaria Bioscience Corp. (LEXX) | $0.084B | -1.92 | |
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |